Hospice News July 17, 2024
UnitedHealth Group’s (NYSE: UNH) subsidiary Optum, which holds a substantial home health and hospice business, continuesto be a major driver of the company’s growth.
Optum is in the process of acquiring the home health and hospice provider Amedisys (NASDAQ: AMED), with closing expected before the end of the year, pending some regulatory hurdles. Optum last June penned its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion.
The Amedisys deal is among a slew of large acquisitions by Optum, which include the home health and hospice provider LHC Group and the health care tech company Change Healthcare. Optum closed its $5.4 billion acquisition of LHC Group in February 2023.
During Q2, Optum’s home-based...